In spring 2010 the Academy of Medical Sciences was invited by Government to review
the regulation and governance of health research involving human participants, their
tissue or their data. A working group chaired by Sir Michael Rawlins FMedSci was
convened to undertake the review. The group received over 300 submissions from
across industry, academia, the NHS, charities and public sector bodies, as well as from
regulators themselves. There was a broad consensus about the key problems, and a
clear desire from those consulted to see the position improved.